These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 10958251

  • 1. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K, Smith SE, Sharp T.
    J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
    [Abstract] [Full Text] [Related]

  • 2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 3. Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D1-like and D2-like dopamine receptors.
    Smith SE, Sharp T.
    Psychopharmacology (Berl); 1997 Sep; 133(1):77-84. PubMed ID: 9335084
    [Abstract] [Full Text] [Related]

  • 4. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML, Currie RW, Robertson HA.
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [Abstract] [Full Text] [Related]

  • 5. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK, Platt DM, Yao WD, Spealman RD.
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [Abstract] [Full Text] [Related]

  • 6. Behavioural response to SKF 38393 and quinpirole following chronic antidepressant treatment.
    Allison K, Ivanová S, Greenshaw AJ.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):139-44. PubMed ID: 7493601
    [Abstract] [Full Text] [Related]

  • 7. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.
    Ainsworth K, Smith SE, Zetterström TS, Pei Q, Franklin M, Sharp T.
    Psychopharmacology (Berl); 1998 Dec 24; 140(4):470-7. PubMed ID: 9888623
    [Abstract] [Full Text] [Related]

  • 8. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE, Holtzman SG.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):65-75. PubMed ID: 7813580
    [Abstract] [Full Text] [Related]

  • 9. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN, Abraini JH.
    Neuropharmacology; 2001 Sep 01; 41(4):454-63. PubMed ID: 11543765
    [Abstract] [Full Text] [Related]

  • 10. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 01; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 11. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep 01; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 01; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 13. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR, Brooderson RJ, White FJ.
    Psychopharmacology (Berl); 1992 Sep 01; 109(1-2):41-8. PubMed ID: 1365670
    [Abstract] [Full Text] [Related]

  • 14. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H, Gerlach J, Peacock L.
    Clin Neuropharmacol; 1992 Dec 01; 15(6):448-58. PubMed ID: 1362136
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    Bergman J, Rosenzweig-Lipson S, Spealman RD.
    J Pharmacol Exp Ther; 1995 Apr 01; 273(1):40-8. PubMed ID: 7714795
    [Abstract] [Full Text] [Related]

  • 16. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 17. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O, Morelli M.
    Psychopharmacology (Berl); 2002 Jul 28; 162(3):246-54. PubMed ID: 12122482
    [Abstract] [Full Text] [Related]

  • 18. The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists.
    Bratcher NA, Farmer-Dougan V, Dougan JD, Heidenreich BA, Garris PA.
    J Exp Anal Behav; 2005 Nov 28; 84(3):371-99. PubMed ID: 16596971
    [Abstract] [Full Text] [Related]

  • 19. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O.
    Behav Pharmacol; 2002 Dec 28; 13(8):633-8. PubMed ID: 12478213
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M, Dekeyne A, Papp M, Millan MJ.
    Behav Pharmacol; 2006 Nov 28; 17(7):559-72. PubMed ID: 17021388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.